udaibanerji @udai_banerji
Passionate about Molecular Cancer Pharmacology and the need to think out of the box. Joined July 2016-
Tweets352
-
Followers1K
-
Following46
-
Likes6K
Medicine intersects with physics. Targeting tumours with ultrasound and microbubbles to increase delivery of standard chemotherapy in tumour tissue. Achieving proof of concept in metastatic CRC (NCT04021277) Abst 6221 #AACR2024 @ICR_London @TheRMH @CRUKConvergence @ECMC_UK
New frontiers in exploiting stroma for therapy. FAP directed precision medicine. Phase I of AVA600 showing tolerability, plasmas/tumour PK and clinical proof of concept response in FAP high tumours. Abstract CT188 #AACR2024 @ICR_London @royalmarsdenNHS @ECMC_UK
Messing with (cancer cell) stress. PK-PD and toxicity of the dose escalation cohort of NXP800 (NCT05226507) Abst CT111 at #AACR2024. Target engagement confirmed, next steps to evaluate efficacy in ARID1A mutated tumours. @ICR_London @TheRMH @ECMC_UK @RMresearch_
First report on the Phase-1 Clinical Trial (ASTEROID) by DDU-IIT team. Looking forward to Crescens' Oral Presentation at AACR on 8th April 2024
Fantastic to be reunited with Rachel Lau during PhD graduation function #ICRGrad Proud she is blazing her way through her 1st post doc. Her work on CAF proteome/secretome opened many research avenues. The future is 🌞! @ICR_London @royalmarsdenNHS @NIHRresearch
Crucial to expose next generation of university students to careers in life sciences and clinical trials.Proud to bring work experience students together from academia,charities and pharma.@ICR_London @royalmarsdenNHS @CR_UK @ECMC_UK @NIHRresearch #resilientlifescienceworkforceUK
The future is bright! Clinical Fellow Dr Alvaro Garces sucessfuly defended his PhD. Cancer evolution in ovarian cancer can be can be understood and possibly exploited.... @ICR_London @royalmarsdenNHS @BanerjeeSusana @AndreaSottoriva @trevoragraham @CR_UK
Optimizing Optimus. Change in the way we do phase I trials is necessary and we have to do so thoughtfully... pubmed.ncbi.nlm.nih.gov/38129533/ @ICR_London @royalmarsdenNHS @ECMC_UK @ICR_DDU_IIT
Stroma, the new frontier. Elegant papers
Stroma, the new frontier. Elegant papers
The heart and soul of our research institution. Super-intelligent caring people who chose to do this job to make a difference to cancer patients. 👏👏👏 @ICR_London @royalmarsdenNHS @ECMC_UK @CR_UK @NIHRresearch
The heart and soul of our research institution. Super-intelligent caring people who chose to do this job to make a difference to cancer patients. 👏👏👏 @ICR_London @royalmarsdenNHS @ECMC_UK @CR_UK @NIHRresearch
Very interesting but frightening read, pointing to heritable rewiring of the epigenome as a player in drug resistance. We will need to rethink our current strategies of treating patients with metastatic disease pubmed.ncbi.nlm.nih.gov/37331179/
Very interesting but frightening read, pointing to heritable rewiring of the epigenome as a player in drug resistance. We will need to rethink our current strategies of treating patients with metastatic disease pubmed.ncbi.nlm.nih.gov/37331179/
An important message for early phase cancer clinical trialists. We ask for a lot from our patients who selflessly give up their time. 🤔Think before you ask for more visits, investigations, or questionnaires in your protocols. @ICR_London @royalmarsdenNHS @ECMC_UK @NIHRresearch
An important message for early phase cancer clinical trialists. We ask for a lot from our patients who selflessly give up their time. 🤔Think before you ask for more visits, investigations, or questionnaires in your protocols. @ICR_London @royalmarsdenNHS @ECMC_UK @NIHRresearch
Lot to learn from phase I trials. The jigsaw of evidence from the pharmacological audit trail studying ATR inhibitors pubmed.ncbi.nlm.nih.gov/37934611/. Stellar job of an investigator initiated trial from colleagues @ICR_London @royalmarsdenNHS @drmagnusd @ECMC_UK @NIHRresearch @cruk
📜👩🎓Applications are now open for our 2023/24 fully-funded #PhD studentships. Check out our PhD projects and apply⬇️⬇️ icr.ac.uk/studying-and-t…
📜👩🎓Applications are now open for our 2023/24 fully-funded #PhD studentships. Check out our PhD projects and apply⬇️⬇️ icr.ac.uk/studying-and-t…
#TargetingRAS Presenting at an amazing RAS focussed meeting of academia/industry/patient advocacy groups. Science is moving at warp speed (inhibitors of G12C, G12D, pan RAS, Ras interactors/effectors), need to translate this to patient benfit ASAP. @ICR_London @royalmarsdenNHS
Could not agree more,smoking kills not just due to cancer but also strokes and heart attacks. Nicotene is addictive. Beware of free samples of buccal tobacco pouches being handed out free in music festivals, the tobacco industry is still looking to increase its base. #smokefreeUK
Could not agree more,smoking kills not just due to cancer but also strokes and heart attacks. Nicotene is addictive. Beware of free samples of buccal tobacco pouches being handed out free in music festivals, the tobacco industry is still looking to increase its base. #smokefreeUK
Now that (most of the) low hanging fruit have been picked, is time to look for anticancer targets elsewhere? Fantastic work from past PhD student and now post-doc @RLau_ICR . Peek into the CAF proteome... pubmed.ncbi.nlm.nih.gov/37481068/ @ICR_London @royalmarsdenNHS @cancerBRC @CR_UK
Cancer evolution is well documented. So what are we going to be doing about it? Multidisciplinary conversations needed... pubmed.ncbi.nlm.nih.gov/37331179/ @ICR_London @royalmarsdenNHS @cancerBRC @ECMC_UK @CR_UK @trevoragraham @NPortaStat
Elegant explanation of evolutionary concepts of adaptive therapy. Current focus on targeted treatment but one day we be able to deconstruct a few complex chemotherapy combinations to improve survival and certainly improve QOL....
Elegant explanation of evolutionary concepts of adaptive therapy. Current focus on targeted treatment but one day we be able to deconstruct a few complex chemotherapy combinations to improve survival and certainly improve QOL....
Refresusted (refreshed+exhausted) after working with young investigators and faculty in the Methods in Clinical Cancer Research Workshop 2023. Great new ideas and energy in cancer research. #MCCR2023 @myESMO @EORTC @AACR @ICR_London @royalmarsdenNHS
The ICR @ICR_London
24K Followers 2K Following The Institute of Cancer Research is making the discoveries that defeat cancer. We're a top UK academic research centre, a postgrad college, and a charity.
Adam Sharp @AdamSharpMedOnc
4K Followers 3K Following Academic medical oncologist. Interested in biology, prostate cancer and drug development. Husband/Dad/Sport. Views my own and no specific advice/DMs.
Rossanese Lab @TEMT_ICR
836 Followers 801 Following Target Evaluation and Molecular Therapeutics Team @ICR_London
Ophidian @Ophidian18
3K Followers 106 Following Scientist, Conservationist, Traveller, Investor, very lucky Husband & super proud Dad of two wonderful strong independent grown-up people. - oh and Golf nut.
Vivek Subbiah, MD @VivekSubbiah
34K Followers 2K Following Chief, Early-Phase Drug Development|@SarahCannonDocs #Oncologist, #Phase1trials, #PrecisionMedicine. Tweets=My own.
Cellar boy @boy_cellar
1K Followers 387 Following Derivatives trader. AIM investing with a focus on Biotech.
Science and Innovatio.. @CRUKresearch
25K Followers 2K Following We're here to support our broad cancer research community of 4,000 scientists and clinicians. For general Cancer Research UK news & fundraising follow @CR_UK
Avacta @avacta
8K Followers 263 Following We develop safe and efficacious drugs and high performance diagnostics, based on our proprietary Affimer® and pre|CISIONᵀᴹ platforms.
Charles Swanton @CharlesSwanton
15K Followers 819 Following Francis Crick Institute and UCL Hospitals @CR_UK Cancer Evolution and Genome Instability Lung Oncologist Air Pollution and Drug Resistance Fair Weather 🚴
Michelle Mitchell @Michelle_CRUK
10K Followers 3K Following Chief Executive at Cancer Research UK @CR_UK. Views my own.
ICR-CTSU @ICR_CTSU
1K Followers 323 Following Clinical Trials and Statistics Unit @ICR_London. Translating cutting-edge science into quality clinical trials that can transform cancer care.
Alison Tree 💙🇺�.. @alison_tree
4K Followers 750 Following Oncologist @royalmarsdenNHS, passionate about radiotherapy (among other things). Views are all mine.
JonesLabICR @JonesLabICR
378 Followers 200 Following
Sebastian Guettler La.. @SGuettlerLab
698 Followers 544 Following The Guettler Lab @ICR_London studies cell signalling using biochemistry, structural biology and cell biology.
Jon Lim @DrJonLim
1K Followers 1K Following Medical Oncologist • Postdoc @TurajlicLab • #ImmunoOncology • @myESMO #TranslationalResearch Faculty, #ESMORTF, #ESMOLGP '23-24, @OncMedEdCoP #Mentorship • 🎾
Ben Kolbington @thebenkolb
3K Followers 5K Following Deputy Director & Head of Comms @ICR_London, previously research comms @TheBHF. All my own views. #SciComm, #PR, #Comms, #CharityComms
Maggie Cheang @MaggieCheang
687 Followers 687 Following Team Leader, Genomic Analysis of Clinical Trial, ICR, interest in molecular pathology, biomarker discovery, machine learning, clinical trials
Sareum Holdings plc @Sareumplc
2K Followers 420 Following Sareum is a drug discovery & development co. producing targeted small molecule therapeutics for the treatment of cancer and autoimmune diseases. Tag with $SAR.L
Caroline Richardson �.. @richardson_cara
2K Followers 3K Following RT= look•• Favourite = bookmark and/or like•• RT+Favourite = agree and/or like•• always aiming for balance
richard @richard23751286
24 Followers 36 Following
Roomy @Paul26657963
128 Followers 209 Following Army Veteran honesty and loyalty a must hate bullshiters
Thin Izzy @IzzyThin
26 Followers 205 Following
Mike Wilk @Mike182035
39 Followers 30 Following
Víctor Panama @panama_vic99038
4 Followers 37 Following
Kamil R Kranc @kamilkranc
406 Followers 461 Following Professor of Haemato-Oncology & Director of Centre for In Vivo Modelling, The Institute of Cancer Research, London, UK
Tony Ive @IveTony77539
0 Followers 25 Following
terllerice @terllerice
239 Followers 5K Following
UNSULLIED IMPALER @EkunsiB9787
8 Followers 41 Following Anti JagaBandit and seeker of justice for the Nigerian electorate WE WILL TAKE NIGERIA BACK FROM THE CAREER POLITICAL CRIMINALS AND CORRUPT JUDICIARY
señor Marco Honez @Doc_Jonesy
33 Followers 98 Following
J @jegpearson
30 Followers 121 Following
Giulia Zuccaroli @GiuliaZucc73867
0 Followers 14 Following
RetailPunter @AimlessInvestor
41 Followers 54 Following
Ralf23 @Ralf2314
104 Followers 386 Following Familie, Basketball, Ökonomie und der Wahnsinn, der Methode hat
Jeffrey Rubasingham @jeffreyrubasin1
123 Followers 239 Following Specialist Registrar in Clinical Oncology; views are my own
Florian “Drei Früh.. @BeckettFlorian
97 Followers 387 Following The heat and humidity really test’s a kitten….
Resident @BartonResident
169 Followers 205 Following
David _ Bryant @davidrbryant8
45 Followers 86 Following M&A Integration Specialist, e-Commerce Business Owner and Investor
Rick Healey @rmjhealey
73 Followers 244 Following
K Lofts @Moi1964589
2 Followers 7 Following
Interests54321 @Interests54321
24 Followers 239 Following
Ashley Scott @Ashscott1987
14 Followers 95 Following
Allan Matthews @allan_matthew5
3 Followers 32 Following
jeremy chantry @jeremychantry1
31 Followers 228 Following
B2HS2L @b2_hs2
33 Followers 48 Following
Aly-Khan @AlyKhan_Mak
407 Followers 749 Following Anaesthetic trainee and Professional Procrastinator.
James Kirrane @JESKirrane
274 Followers 220 Following
Jen Lovick, PhD Journ.. @drjkyl
1K Followers 5K Following Executive Editor Gold #OpenAccess Journals @ Sage Publishing, Technology in Cancer Research & Treatment @TCRT_Cancer (IF 2.8) Comments/Opinions=mine #oncology
Shep @MailShep
13 Followers 186 Following
fullbreakfast @fullbreakfast
60 Followers 193 Following
Mike Holbrook @MikeHolby
57 Followers 303 Following Retired after a lifetime in metals, worked for Rio Tinto, Mount Isa Mines and Xstrata. Investing to grow my personal pension pot.
amy d @aldrugby
39 Followers 168 Following freelance delivery trainer loves rugby league and holidays in the sun
Annette @annettect8
817 Followers 881 Following Getting more left-wing the older I get. Reluctant Gooner.
Stephen Loten @stephen_loten
130 Followers 343 Following
jc @jcannan01
11 Followers 153 Following
Mark brennan @Markyb490
58 Followers 69 Following
Andy Howes @HowesyUK
27 Followers 86 Following
Oliver Smith @Smiffy_O
503 Followers 612 Following AIM Investor rather than trader! Positions in #EUA #AVCT
The ICR @ICR_London
24K Followers 2K Following The Institute of Cancer Research is making the discoveries that defeat cancer. We're a top UK academic research centre, a postgrad college, and a charity.
Adam Sharp @AdamSharpMedOnc
4K Followers 3K Following Academic medical oncologist. Interested in biology, prostate cancer and drug development. Husband/Dad/Sport. Views my own and no specific advice/DMs.
Rossanese Lab @TEMT_ICR
836 Followers 801 Following Target Evaluation and Molecular Therapeutics Team @ICR_London
Vivek Subbiah, MD @VivekSubbiah
34K Followers 2K Following Chief, Early-Phase Drug Development|@SarahCannonDocs #Oncologist, #Phase1trials, #PrecisionMedicine. Tweets=My own.
Charles Swanton @CharlesSwanton
15K Followers 819 Following Francis Crick Institute and UCL Hospitals @CR_UK Cancer Evolution and Genome Instability Lung Oncologist Air Pollution and Drug Resistance Fair Weather 🚴
ICR-CTSU @ICR_CTSU
1K Followers 323 Following Clinical Trials and Statistics Unit @ICR_London. Translating cutting-edge science into quality clinical trials that can transform cancer care.
The Royal Marsden NHS.. @royalmarsdenNHS
12K Followers 647 Following World-leading cancer centre. Channel is monitored weekdays 9am - 5pm. Follow our charity: @royalmarsden
Sanjay Popat @DrSanjayPopat
7K Followers 592 Following Thoracic Oncologist @royalmarsdenNHS, Professor @ICR_London; Chair @BTOGorg; views are my own.
Trevor Graham @trevoragraham
4K Followers 654 Following Director, Centre for Evolution & Cancer @CEC_ICR @ICR_London Mixing maths, genomics & evolution. Early detection, metastasis & drug resistance. Bowel cancer.
WinetteVanDerGraaf @Winette_vdGraaf
3K Followers 2K Following Medical Oncologist @NKI_nl Amsterdam. Sarcoma; AYA cancer. Prof. @ErasmusMC President of @EORTC, chair @AYAzorgnetwerk @COMPRAYA_study @strong_AYA
Razelle Kurzrock, MD @Dr_R_Kurzrock
7K Followers 5K Following Momx7 (4 children; 3 dogs); wife; Precision/Rare diseases; MCW AD; CMO WIN; physician, not provider; Board CureMetrix/CureMatch (cofounder); opinions mine
Kristian Helin @helin_kristian
2K Followers 673 Following
Drug Development Unit @ICR_RM_DDU
43 Followers 25 Following A phase 1 clinical trials unit providing a seamless transition of hypothesis driven novel cancer drugs from bench to bedside, addressing unmet patients' needs.
Inclusive @InclusiveGrid
1K Followers 669 Following Inclusive (powered by Research Grid) is a complete solution for community engagement.
Sujai Banerji @sujai_banerji
156 Followers 690 Following Ph.D. student at INAR, UHEL; M.S. from UAF; Aerosol Optical Properties; Host of The Science Basement podcast; Ph.D. student by day, podcaster by night.
Anubhuti Bhatnagar, D.. @banubhuti
159 Followers 417 Following Post-Doctoral Researcher at Aalto University. Currently working on Social Life-Cycle Assessment.
Julian Downward @JulianDownward
1K Followers 115 Following Cancer biologist at the Francis Crick Institute. Working to develop cures for lung cancer by reactivating the body's immune system against the tumour.
Céire Costelloe @ProfCCostelloe
1K Followers 2K Following Professor Health Informatics, CStat @ICR_London @royalmarsdenNHS | Digital Health lead @ARC_NWL | past Director @dighealthimp #stats #digitalhealth #healthdata
Chris Tape @christophertape
4K Followers 2K Following Group Leader at @uclcancer. Studying how different cell-types collaborate to drive cancer.
Mara Vinci @MaraVinci2
216 Followers 133 Following DIPG and pHGG research scientist #DIPG #Pediatriccancer #3DBiology
chrisglynn @chrisglynn
294 Followers 493 Following Audience analyst, dad, ale and wine drinker, chilli grower, sometime-singer, owner of naughty dog. Views my own.
Professor Dame Sue Hi.. @CSOSue
11K Followers 8K Following I am the Chief Scientific Officer for England and the Senior Responsible Officer for Genomics in the NHS
Centre for Evolution .. @CEC_ICR
282 Followers 108 Following Interdisciplinary research to predict cancer evolution & improve treatment. @trevoragraham @BezziLab_ICR @PaedCancerEvol @AndreaSottoriva @nearlobey @luisglsz
Pedro Ballester @pjballester
1K Followers 863 Following Royal Society Wolfson Fellow & SL at Imperial College London. Editor at @OxfordJournals Briefings in #Bioinformatics, @Nature_NPJ #PrecisionOncology, + others.
Alex Georgiou @Alex__Georgiou
137 Followers 179 Following Medical Oncology Consultant at Guy’s and St Thomas’ and King’s College Hospital (PRUH) London, Honorary Senior Lecturer King’s College London @GSTTnhs
Functional Proteomics @Proteomics_ICR
278 Followers 85 Following This is the twitter account for Functional Proteomics group at The Institute of Cancer Research @ICR_London
ICR_DDU_IIT @ICR_DDU_IIT
227 Followers 147 Following We are the Investigator Initiated Trials team within the @ICR_London Drug Development Unit. We sponsor innovative Phase I trials of novel anti-cancer agents.
Susana Banerjee @BanerjeeSusana
1K Followers 71 Following Consultant Medical Oncologist, Royal Marsden, Team Leader ICR All views my own
Christina Yap @ChristinaBYap
779 Followers 261 Following Professor of Clinical Trials Biostatistics. Group Leader Early Phase & Adaptive Trials. Interested in efficient trial designs & analysis @ICR_CTSU @ICR_London
Martijn Lolkema @MartijnLolkema
515 Followers 518 Following Medical Director @Amgen. Early Drug Development. Tweets are my own.
NIHR Royal Marsden BR.. @RMresearch_
1K Followers 472 Following Our vision is to improve outcomes for everyone at risk of and affected by cancer. Home of #NIHRRoyalMarsdenBRC with @ICR_London and #NIHRRoyalMarsdenCRF.
Nature Cancer @NatureCancer
33K Followers 303 Following Nature Cancer is a journal dedicated to publishing the latest advances across all areas of cancer research.
Andrea Sottoriva @AndreaSottoriva
4K Followers 377 Following Professor of Cancer Genomics & Evolution Head of Computational Biology Research Centre @ Human Technopole, Milan
Anguraj Sadanandam @LabSadanandam
1K Followers 1K Following Developed first time PDAC,PanNET, CRC subtypes;precision medicine;machinelearning;diagnosis;preclinical trial;Global Oncology; digitaltwin;entrepreneur (my own)
Chris Lord @lordoflard
163 Followers 212 Following Ageing scientist with heavily airbrushed profile pic. All views own etc..
Brent O'Carrigan @brentocarrigan
720 Followers 2K Following Medical oncologist melanoma & RCC @CUH_NHS; PhD candidate @CRUK_CI @Cambridge_Uni; Co-lead @CRUKCamUrol; Clinical Cancer Lead @East_Genomics. Views my own.
Richard Baird @Richard_Baird
74 Followers 105 Following Breast Cancer and Drug Development Specialist @CRUKCambridge @NHS. Tweets are my own and not medical advice.
Steven Whittaker @srwhittaker
119 Followers 194 Following Molecular pharmacologist working to combat drug resistance and devise new therapeutic strategies for cancer treatment.
ECMC Network @ECMC_UK
3K Followers 2K Following Experimental Cancer Medicine Centres develop new cancer therapies. Jointly funded @CR_UK @LPTrustUK @NIHRresearch @CSO_Scotland @ResearchWales @BelfastTrust
Nature Portfolio @NaturePortfolio
2.2M Followers 2K Following Nature Portfolio’s high-quality products and services across the life, physical, chemical and applied sciences is dedicated to serving the scientific community.
Robin Lewis Jones @RobinL_Jones
2K Followers 2K Following Head of #Sarcoma Unit at @royalmarsdenNHS. Team Leader of Sarcoma Trials for @ICR_London. All personally tweeted views are my own.
Dr Elizabeth Coker @LizzieCoker
2K Followers 3K Following Data scientist modelling drug combinations to improve patient outcomes. Views my own, she/her 🇪🇺
Journal of Clinical O.. @JCO_ASCO
50K Followers 1K Following @ASCO's credible, authoritative resource for disseminating clinical oncology research. Home of @JCOOP_ASCO, @JCOGO_ASCO, @JCOCCI_ASCO, & @JCOPO_ASCO.
NatureRevClinOncol @NatRevClinOncol
40K Followers 250 Following The latest clinical diagnostic, treatment & personalized medicine advances & more from Nature Reviews Clinical Oncology, a reviews journal. Tweets by the eds.Joining us at #CRUKBrain24 is Juanita Lopez whose research focusses on immune-responses in #Cancer to develop novel treatments including the first-in-brain 5G molecular hypotheses testing platform. Hear more from Juanita 👉 bit.ly/3wecdd9 @royalmarsdenNHS | @ICR_London
"Pay for Open Access, I don't care how much it costs"
Once again I can only assume this is how oncology drugs get their names
FDA Approves Nogapendekin Alfa Inbakicept Plus BCG for BCG-Unresponsive NMIBC onclive.com/view/fda-appro… via @OncLive
▪︎Avutometinib/ defactinib maintains exceptionally high tumor response rates in heavily pretreated patients with recurrent LGSOC, similar TRAE incidence in 1-3 or ≥4 prior LOT. ▪︎KRAS mutation not necessary for response (m/wt) ▪︎Consider moving this trial to the frontline
Today, The Royal Marsden launched its Five-Year Clinical Strategy, in partnership with @ICR_London. For more information about new strategy, and to see our achievements from the past five years, visit: bit.ly/4aVCAno
@ElizSMcKenna @danwpaterson @VivekSubbiah @udai_banerji @VerastemOncolog @Mirati @BrunaPellini @DrShubhamPant @KRASKickers @StephenVLiu Interestingly, on-target activity of MRTX0902 can be monitored non-invasively as a surrogate for tumor tissue using whole blood. Co-administration of MRTX0902 with avutometinib demonstrated increased efficacy and was well-tolerated with no adverse side effects in mice. 🎯 #KRAS
The SOS1 Inhibitor MRTX0902 Blocks KRAS Activation and Demonstrates Antitumor Activity in Cancers Dependent on KRAS Nucleotide Loading. 🔻 doi.org/10.1158/1535-7…
Super thanks to @CharlesSwanton for taking the time out to visit us minions at #BTOG24 and update us all on the amazing work going on in the preclinical space. The talk was stellar
⭐️📍 Before heading to @AACR #AACR24, celebrating an ASCO @ASCO Announcement! 👉🏼Congrats to @IshwariaMD earning the Fellow of ASCO recognition #FASCO ! 🎉 Her dedication to clinical trials access & oncology professional wellbeing is second only to her ability to…
Join us in congratulating the following members on earning the Fellow of ASCO (FASCO) distinction this quarter! We're grateful for your extraordinary volunteer service, dedication, and commitment to ASCO. More about FASCO: brnw.ch/21wIvxP
Registrations are still open for our upcoming event held at the @ICR_London exploring our latest research into breast and gynaecological cancer. To register please visit: cancerbrc.org/news-events/ev… #breastcancer #gynaecologicalcancer #CancerResearch
Don’t underestimate the beyond project impact of fellowships. @acmedsci @ProstateUK @NIHRresearch @The_MRC @PCF_Science @wellcometrust have supported me over the past 10 years. Thank you does not seem enough.
Dr Adam Sharp received a clinical lectureship grant in partnership with @ProstateUK + @acmedsci in 2015 🤝 His work explored how the androgen receptor 'shapeshifts' to evade hormone therapy in #prostatecancer, identifying new treatment targets Read more: bit.ly/3TJwgIG
First report on the Phase-1 Clinical Trial (ASTEROID) by DDU-IIT team. Looking forward to Crescens' Oral Presentation at AACR on 8th April 2024
The ECMC Programme Office are at the pan-Scotland ECMC meeting today. Great to hear about all the exciting work in the region and the focus on equitable trial delivery! @ECMC_Glasgow @ECMC_UK Edinburgh
Very honoured to have received the CRUK 2024 Horizons Explorer Recognition Award for our p110 PI3K activator work with Roger Williams @MRC_LMB - Also what are the odds to have received the (p)110 cloakroom ticket too? @CRUKresearch @CR_Horizons @uclcancer bit.ly/4akaj9G
Our first ever Student Symposium, an effort to build future clinical trials workforce, provided an opportunity to our sandwich year students, students from academic / industry partners and the HRA to gain an insight into our site functions, site facilities and the HRA processes.
@TomasNugent @Decscfc1990 @AACR @udai_banerji @ICR_London @royalmarsdenNHS @avacta #AVCT is redefining #oncology. Realisation will kick in at some point. #AACR #AACR24
Cancer-associated fibroblast phenotypes are associated with patient outcome in non-small cell lung cancer dlvr.it/T3zLZH
Thank you
Did an interview with the daily express this week arranged by PCUK. It was published today, hope it makes a difference and raises awareness 😀🤞👍
Trends for United States
You might like
